Arkolith/Insider Trading/SNDX/Form 4

Meury William

DirectorSyndax Pharmaceuticals Inc (SNDX) · full profile →Form 4 · filed Aug 3, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 2, 2023Sell(S)24K$20.45$491K48K
Aug 2, 2023Option exercise(M)35K$7.11$249K83K
Aug 2, 2023Option exercise(M)24K$9.47$227K72K
Aug 2, 2023Sell(S)24K$20.46$491K48K
Aug 2, 2023Option exercise(M)24K$7.88$189K72K
Aug 2, 2023Sell(S)35K$20.46$716K48K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 2, 2023Option exercise(M)24K—$00
Aug 2, 2023Option exercise(M)35K—$00
Aug 2, 2023Option exercise(M)24K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-23-006130) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML